subcutaneous injection

  1. N

    Biocon Launches Two Biosimilars for Bone Conditions in US

    New Delhi, April 7 Biocon Ltd announced on Tuesday the commercial launch of biosimilars Bosaya and Aukelso, indicated for different serious bone conditions, in the US.Bosaya (a biosimilar to Prolia) and Aukelso (a biosimilar to Xgeva) are now available by prescription nationwide through...
  2. M

    Preventive Therapy Boosts Hemophilia Treatment in Karnataka

    Bengaluru, February 25 The Karnataka government on Wednesday launched the 'Kusuma Sanjeevini' scheme—a major initiative aimed at supporting people living with hemophilia.Unlike conventional care, which treats bleeding after it occurs, this initiative focuses on preventing bleeding episodes...
Back
Top